Zacks Research Issues Optimistic Forecast for MD Earnings

Key Points

• Zacks Research has raised its Q1 2026 earnings per share estimate for Pediatrix Medical Group from $0.24 to $0.25, maintaining a "Strong-Buy" rating on the stock.
• The company reported a Q2 2026 earnings estimate of $0.41 EPS and achieved $0.53 EPS in its last quarterly report, exceeding analyst expectations.
• Analysts have variously rated Pediatrix Medical Group as "Moderate Buy" with an average target price of $16.75; this includes one "Strong Buy," two "Buy," and four "Hold" ratings.

Pediatrix Medical Group, Inc. (NYSE:MD - Free Report) - Equities researchers at Zacks Research increased their Q1 2026 earnings per share estimates for shares of Pediatrix Medical Group in a report released on Tuesday, August 19th. Zacks Research analyst Team now forecasts that the company will earn $0.25 per share for the quarter, up from their prior estimate of $0.24. Zacks Research has a "Strong-Buy" rating on the stock. The consensus estimate for Pediatrix Medical Group's current full-year earnings is $1.38 per share. Zacks Research also issued estimates for Pediatrix Medical Group's Q2 2026 earnings at $0.41 EPS.

A number of other research firms have also recently commented on MD. UBS Group lifted their target price on shares of Pediatrix Medical Group from $16.00 to $16.50 and gave the stock a "neutral" rating in a research note on Thursday, August 14th. Macquarie lifted their target price on shares of Pediatrix Medical Group from $19.00 to $20.00 and gave the stock an "outperform" rating in a research note on Thursday, May 8th. One investment analyst has rated the stock with a Strong Buy rating, two have given a Buy rating and four have assigned a Hold rating to the company's stock. According to MarketBeat, Pediatrix Medical Group presently has a consensus rating of "Moderate Buy" and a consensus target price of $16.75.

Pediatrix Medical Group Trading Up 1.1%

Pediatrix Medical Group stock traded up $0.19 during trading hours on Friday, hitting $17.22. The company had a trading volume of 214,208 shares, compared to its average volume of 753,282. The company has a 50-day moving average price of $13.90 and a two-hundred day moving average price of $13.98. The firm has a market cap of $1.50 billion, a P/E ratio of 13.35 and a beta of 1.21. The company has a debt-to-equity ratio of 0.70, a quick ratio of 1.80 and a current ratio of 1.80. Pediatrix Medical Group has a 1 year low of $10.06 and a 1 year high of $17.67.

Pediatrix Medical Group (NYSE:MD - Get Free Report) last announced its earnings results on Tuesday, August 5th. The company reported $0.53 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.42 by $0.11. The firm had revenue of $468.84 million for the quarter, compared to analysts' expectations of $464.37 million. Pediatrix Medical Group had a net margin of 5.66% and a return on equity of 18.94%. The business's revenue was down 7.1% compared to the same quarter last year. During the same period in the prior year, the company earned $0.34 EPS.

Hedge Funds Weigh In On Pediatrix Medical Group

A number of hedge funds and other institutional investors have recently bought and sold shares of the company. California State Teachers Retirement System grew its stake in Pediatrix Medical Group by 0.9% during the 4th quarter. California State Teachers Retirement System now owns 80,327 shares of the company's stock worth $1,054,000 after purchasing an additional 752 shares in the last quarter. AlphaQuest LLC raised its position in Pediatrix Medical Group by 16.0% in the 1st quarter. AlphaQuest LLC now owns 5,877 shares of the company's stock valued at $85,000 after purchasing an additional 811 shares in the last quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management lifted its holdings in Pediatrix Medical Group by 8.7% during the 2nd quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management now owns 11,913 shares of the company's stock worth $171,000 after buying an additional 950 shares during the last quarter. SummerHaven Investment Management LLC lifted its holdings in Pediatrix Medical Group by 0.9% during the 1st quarter. SummerHaven Investment Management LLC now owns 112,327 shares of the company's stock worth $1,628,000 after buying an additional 1,028 shares during the last quarter. Finally, New York State Common Retirement Fund lifted its holdings in Pediatrix Medical Group by 1.7% during the 2nd quarter. New York State Common Retirement Fund now owns 62,245 shares of the company's stock worth $893,000 after buying an additional 1,034 shares during the last quarter. 97.71% of the stock is currently owned by hedge funds and other institutional investors.

About Pediatrix Medical Group

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.